This trial is testing the effectiveness of iopofosine I 131 in treating patients with various types of B-cell malignancies.
2 Primary · 9 Secondary · Reporting Duration: 3 years
Experimental Treatment
120 Total Participants · 8 Treatment Groups
Primary Treatment: Iopofosine I 131 multiple dose · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: